Omicron News and Research

RSS

Meta-analysis of population-based seroprevalence studies to estimate SARS-CoV-2 seroprevalence in Africa

Researchers conducted a descriptive meta-analysis to estimate the seroprevalence of SARS-CoV-2 infections in Africa.

18 Feb 2022

Study explores efficacy of mRNA vaccine booster doses during the SARS-CoV-2 Omicron wave

Researchers evaluated the efficacy of an mRNA vaccine booster dose against severe acute respiratory syndrome coronavirus-2 during the Omicron surge.

18 Feb 2022

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

A recent study explored the safety, immunogenicity, and VE of the SARS-CoV-2 mRNA BNT162b2 and mRNA1273 vaccines against its Omicron VOC in HCWs in Israel.

18 Feb 2022

As covid slogs on, seniors find fortitude waning and malaise growing

Late one night in January, Jonathan Coffino, 78, turned to his wife as they sat in bed. "I don't know how much longer I can do this," he said, glumly.

18 Feb 2022

Study shows mink can be infected by Omicron and efficiently transmit the virus to other mink

Researchers have been examining the pathology and spread of the Omicron variant in mink.

18 Feb 2022

Study finds antigenic profile of Omicron RBD is distinct from the prior SARS-CoV-2 variants of concern

A new study aimed to clarify whether extensive RBD mutations could affect the magnitude and immunodominance hierarchy of the host antibody response.

18 Feb 2022

COVID test-to-return may help shorten time away from school

In a recent study posted to the medRxiv* preprint server, a test-to-return approach for students in isolation is explored for its utility in sorting out students who can safely return to school without jeopardizing others, from those with a high viral load.

17 Feb 2022

Study to evaluate efficacy of higher dose of ivermectin for treating mild-to-moderate COVID-19

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of time.

17 Feb 2022

Ensitrelvir, a novel SARS-CoV-2 antiviral

S-217622 reduces the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters.

17 Feb 2022

Faster transmission of SARS-CoV-2 Delta variant in households compared to Alpha

Researchers assess how fast the SARS-CoV-2 Alpha and Delta variants transmit from transmission data in a household study.

17 Feb 2022

Study explores the high viral loads of SARS-CoV-2 Delta and Alpha variants

In a new study, scientists evaluated the cycle threshold values from 1,297 COVID-19-positive saliva samples obtained at a testing lab in the USA.

17 Feb 2022

Study explores humoral and cellular immunity conferred by second and third COVID-19 BNT162b2 vaccination in elderly

Researchers recently assessed SARS-CoV-2-specific humoral and cellular immune responses induced by the second and third doses of the BNT162b2 COVID-19 messenger ribonucleic acid-based vaccine in the elderly.

17 Feb 2022

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

The present study entailed assessments of both infected and uninfected SOTRs against the D614G-CoV2 baseline virus and eight other variants.

17 Feb 2022

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

Researchers recently evaluated the efficacy of the Oxford ChAdOx1 (AZD 1222/ AZD2816) vaccine against the Omicron, Delta, and Beta variants of SARS-CoV-2 in Syrian hamsters.

17 Feb 2022

Memory B cell repertoire in a longitudinal cohort of individuals receiving 3 COVID-19 mRNA vaccine doses

Researchers examined the memory B cell repertoire of individuals immunized with three doses of mRNA-based COVID-19 vaccine.

17 Feb 2022

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

Researchers revealed the co-infection of the SARS-CoV-2 Delta and Omicron variants in two epidemiologically unrelated patients suffering from chronic kidney disease and requiring hemodialysis

17 Feb 2022

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.

17 Feb 2022

Characterization of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military

Researchers discuss the genomic and virological characterization of SARS-CoV-2 variants among unvaccinated and vaccinated U.S military personnel.

16 Feb 2022

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Researchers compare the incidence rate of reinfection in convalescent and unvaccinated people to that in recovered and single-dose vaccinated people.

16 Feb 2022

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Researchers compare the neutralizing antibody titers in individuals who received two or three mRNA vaccine doses and experienced breakthrough infections.

16 Feb 2022

Omicron News and Research

Meta-analysis of population-based seroprevalence studies to estimate SARS-CoV-2 seroprevalence in Africa

Study explores efficacy of mRNA vaccine booster doses during the SARS-CoV-2 Omicron wave

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

As covid slogs on, seniors find fortitude waning and malaise growing

Study shows mink can be infected by Omicron and efficiently transmit the virus to other mink

Study finds antigenic profile of Omicron RBD is distinct from the prior SARS-CoV-2 variants of concern

COVID test-to-return may help shorten time away from school

Study to evaluate efficacy of higher dose of ivermectin for treating mild-to-moderate COVID-19

Ensitrelvir, a novel SARS-CoV-2 antiviral

Faster transmission of SARS-CoV-2 Delta variant in households compared to Alpha

Study explores the high viral loads of SARS-CoV-2 Delta and Alpha variants

Study explores humoral and cellular immunity conferred by second and third COVID-19 BNT162b2 vaccination in elderly

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

Memory B cell repertoire in a longitudinal cohort of individuals receiving 3 COVID-19 mRNA vaccine doses

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Characterization of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News